Tuesday, January 3, 2023: Life Sciences

The House Oversight and Energy and Commerce committees released a report revealing that the Food and Drug Administration’s (FDA) approval for Alzheimer’s drug Aduhelm was “rife with irregularities.” According to the 18-month investigation, officials didn’t...

Tuesday, January 3, 2023: Payers

The Centers for Medicare & Medicaid Services (CMS) released data showing that insurers and providers are overwhelming an arbitration system intended to resolve billing disputes. The system, established under the No Surprise Act, went into effect earlier this year...

Tuesday, January 3, 2023: Payers

Consumers are increasingly using “buy now, pay later” financing options to pay for health care services. A report from the Consumer Financial Protection Bureau found that the loans for health services and products increased from $10 million in 2019 to $230 million in...